Contact us
Thank you for your interest in Riverain Technologies. Whether you’d like to arrange a demo, create a service request, or simply share a question or concern with our team, please contact us. We’re ready to help.
Our ClearRead Chest imaging interpretation solutions are built upon advanced AI algorithms that target the biggest health threats globally. ClearRead accurately and efficiently improves patient outcomes with tools that target pulmonary nodules, coronary artery calcification (CAC), hypodense lung tissue* and pneumothorax.
Lung Cancer
Emphysema*
Pneumothorax
Coronary Artery Calcification (CAC)
Imaging volume has exploded in the last decade, and the complexity of cases continues to grow, contributing to unsustainable workload and burnout. ClearRead Chest is proven to improve accuracy and efficiency and to ease the cognitive load from monotonous, tedious tasks.
ClearRead™ CT is a cardiothoracic AI suite for pulmonary nodule detection, lung tissue analysis*, and coronary artery calcification (CAC) scoring.
ClearRead™ Xray is a unique, patented, and workflow-friendly solution that gives clinicians an unimpaired view of the chest with tools for nodule and pneumothorax detection.
In hospitals, institutions and medical facilities around the world, our products are being put to the test daily to assure that clinicians have the validation they need to confidently screen and assess their patients. See the proof for yourself.
Peer reviews, reference accounts and independent studies confirm our success.
Our effectiveness is validated by real-world success stories from our medical partners.
Browse a variety of videos for greater insight into our technology and its applications.
With over 400 customer locations globally and counting, millions of patients are getting superior lung and cardiac care. Reach out to learn about healthcare providers near you.
“We expected that the results would be in favor of ClearRead CT concerning the detection rate and reading time, but it was surprising that the advantages were so significant.”
